Francisco Diaz-Mitoma
2023
In 2023, Francisco Diaz-Mitoma earned a total compensation of $549.2K as Chief Medical Officer at VBI Vaccines, a 45% decrease compared to previous year.
Compensation breakdown
| Option Awards | $91,305 |
|---|---|
| Salary | $457,916 |
| Total | $549,221 |
Diaz-Mitoma received $457.9K in salary, accounting for 83% of the total pay in 2023.
Diaz-Mitoma also received $91.3K in option awards.
Rankings
In 2023, Francisco Diaz-Mitoma's compensation ranked 1,840th out of 2,773 executives tracked by ExecPay. In other words, Diaz-Mitoma earned more than 33.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,840 out of 2,773 | 34th |
Division Manufacturing | 1,057 out of 1,516 | 30th |
Major group Chemicals And Allied Products | 660 out of 855 | 23rd |
Industry group Drugs | 643 out of 821 | 22nd |
Industry Pharmaceutical Preparations | 459 out of 590 | 22nd |
Source: SEC filing on April 29, 2024.
Diaz-Mitoma's colleagues
We found two more compensation records of executives who worked with Francisco Diaz-Mitoma at VBI Vaccines in 2023.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019